Neurotrophin regulation of gene expression

Canadian Journal of Neurological Sciences

Volumn 24, Issue 4, 1997, Pages 272-283

  Bonni, Azad ^a   Greenberg, Michael E ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROTROPHIN;

CELL SURVIVAL; GENE ACTIVATION; GENE EXPRESSION REGULATION; GROWTH REGULATION; HUMAN; NERVE CELL DIFFERENTIATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; REVIEW; SIGNAL TRANSDUCTION;

EID: 0031424306     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100032935     Document Type: Review

References (131)

1. Levi-Montalcini R. The nerve growth factor 35 years later. Science 1987; 237: 1154-1162.
2. Jelsma TN, Aguayo AJ. Trophic factors. Curr Opin Neurobiol 1994; 4: 717-725.
3. Yuen EC, Mobley WC. Therapeutic potential of neurotrophic factors for neurological disorders. Ann Neurol 1996; 40: 346-354.
4. Ip NY, Yancopoulos GD. The neurotrophins and CNTF: two families of collaborative neurotrophic factors. Ann Rev Neurosci 1996; 19: 491-515.
5. Lewin GR, Barde Y-A. Physiology of the neurotrophins. Ann Rev Neurosci 1996: 19: 289-317.
6. Snider WD. Functions of the neurotrophins during nervous system development: what the knockouts are teaching us. Cell 1994; 77: 627-638.
7. Kalcheim C, Carmeli C, Rosenthal A. Neurotrophin 3 is a mitogen for cultured neural crest cells. Proc Natl Acad USA 1992; 89: 1661-1665.
8. Dicicco-Bloom E, Friedman WJ, Black IB. NT-3 stimulates sympathetic neuroblast proliferation by promoting precursor survival. Neuron 1993; 11: 1101-1111.
9. Levi-Montalcinin R, Booker B. Destruction of the sympathetic ganglia in mammals by an antiserum to a nerve growth factor protein. Proc Natl Acad Sci USA 1960; 46: 384-391.
10. Crowley C, Spencer SD, Nishimura MC, et al. Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons. Cell 1994; 76: 1001-1012.
11. Smeyne RJ, Klein R, Schnapp A, et al. Severe sensory and sympathetic neuropathies in mice carrying a disrupted trk/NGF receptor gene. Nature 1994; 368: 246-249.
12. Hory-Lee F, Russell M, Lindsay RM, Frank E. Neurotrophin 3 supports the survival of developing muscle sensory neurons in culture. Proc Natl Acad Sci USA 1993; 90: 2613-2617.
13. Ernfors P, Lee K-F, Kucera J, Jaenisch R. Lack of neurotropin-3 leads to deficiencies in the peripheral nervous system and loss of limb proprioceptive afferents. Cell 1994; 77: 503-512.
14. Klein R, Silos-Santiago I, Smeyne RJ, et al. Disruption of the neurotrophin-3 receptor gene trkC eliminates Ia muscle afferents and results in abnormal movements. Nature 1994; 368: 249-251.
15. Jones KR, Farinas I, Backus C, Reichardt LF. Targeted disruption of the brain-derived neurotrophic factor gene perturbs brain and sensory neuron but not motor neuron development. Cell 1994; 76: 989-1000.
16. Hefti F. Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections. J Neurosci 1986; 6: 2155-2162.
17. Fischer W, Wictorin K, Bjorklund A. Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor. Nature 1987; 326: 65-68.
18. Ghosh A, Greenberg ME, Distinct roles for bFGF and NT-3 in the regulation of cortical neurosenesis. Neuron 1995; 15: 1-20.
19. Vicario-Abejon C, Johe KK, Hazel TG, Collazo D, McKay RDG. Functions of basic fibroblast growth factor and neurotrophins in the differentiation of hippocampal neurons. Neuron 1995; 15: 105-114.
20. Sendtner M, Holtmann B, Kolbeck R, Thoenen H, Barde Y-A. Brain-derived neurotrophic factor prevents the death of motoneurons in newborn rats after nerve section. Nature 1992; 360: 757-759.
21. Yan Q, Elliot J, Snider WD. Brain-derived neurotrophic factor rescues spinal motor neurons from axotomy-induced cell death. Nature 1992; 360: 753-755.
22. Henderson CE, Camu W, Mettling C, et al. Neurotrophins promote motor neuron survival and are present in embryonic limb bud. Nature 1993; 363: 266-270.
23. Sutter A, Riopelle RJ, Harris-Warrick RM, Shooter EM. Nerve growth factor receptors. Characterization of two distinct classes of binding sites on chick embryo sensory ganglia cells. J Biol Chem 1978; 82: 5972-5982.
24. Chao MV, Bothwell MA, Ross AH, et al. Gene transfer and molecular cloning of the human NGF receptor. Science 1986; 232: 518-521.
25. Johnson D, Lanahan A, Buck CR, et al. Expression and structure of the human NGF receptor. Cell 1986; 47: 545-554.
26. Radeke MJ, Misko TP, Hsu C, Herzenberg LA, Shooter EM. Gene transfer and molecular cloning of the rat nerve growth factor receptor. Nature 1987; 325: 593-597.
27. Chao MV. Neurotrophin receptors: a window into neuronal differentiation. Neuron 1992b; 9: 583-593.
28. Bothwell M. Functional interactions of neurotrophins and neurotrophin receptors. Ann Rev Neurosci 1995; 18: 223-253.
29. Kaplan DR, Hempstead B, Martin-Zanca D, Chao MV, Parada LF. The trk proto-oncogene product: a signal transducing receptor for nerve growth factor. Science 1991a; 242: 554-558.
30. Kaplan D, Martain-Zanca D, Parada LF. Tyrosine phosphorylation and tyrosine kinase activity of the trk proto-oncogene product induced by NGF. Nature 1991b; 350: 158-160.
31. Klein R, Jing S, Nanduri V, O'Rourke E, Barbacid M. The trk proto-oncogene encodes a receptor for nerve growth factor. Cell 1991; 65: 189-197.
32. Greene LA, Tischler AS. PC12 pheochromocytoma cultures in neurobiological research. Adv Cell Neurobiol 1982; 3: 373-414.
33. Halegoua S, Armstrong RC, Kremer NE. Dissecting the mode of action of a neuronal growth factor. Curr Top Microb Immun 1990; 165: 119-170.
34. Loeb D, Maragos J, Martin-Azanca D, Chao MV, Greene LA. The trk proto-oncogene rescues NGF responsiveness in mutant NGF-nonresponsive PC12 cell lines. Cell 1991; 66: 961-966.
35. Hempstead BL, Rabin SJ, Kaplan L, et al. Overexpression of the trk tyrosine kinase rapidly accelerates nerve growth factorinduced differentiation. Neuron 1992; 9: 883-896.
36. McDonald NQ, Lapatto R, Murray-Rust J, et al. New protein fold revealed by a 2.3 A resolution crystal structure of nerve growth factor. Nature 1991; 354: 411-414.
37. Heldin C. Dimerization of cell surface receptors in signal transduction. Cell 1995; 1995: 213-223.
38. Koch CA, Anderson D, Moran MF, Ellis C, Pawson T. SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. Science 1991; 252: 668-674.
39. Cohen GB, Ren R, Baltimore D. Modular binding domains in signal transduction proteins. Cell 1995; 80: 237-248.
40. van der Geer P, Pawson T. The PTB domain: a new protein module implicated in signal transduction. Trends Biochem Sci 1995; 20: 277-280.
41. Songyang Z, Shoelson SE, Chaudhuri M, et al. SH2 domains recognize specific phosphopetide sequences. Cell 1993; 72: 767-778.
42. Obermeier A, Halfter H, Wiesmuller KH, et al. Tyrosine 785 is a major determinant of Trk-substrate interaction. EMBO J 1993a; 12: 933-941.
43. Obermeier A, Lammers R, Wiesmuller K, et al. Identification of trk binding sites for SHC and phosphatidylinositol 3' -kinase and formation of a multimeric signaling complex. J Biol Chem 1993b; 268: 22963-22966.
44. Bar-Sagi D, Feramisco JR. Microinjection of the ras oncogene protein into PC12 cells induces morphologic differentiation. Cell 1985; 42: 841-848.
45. Hagag N, Halegoua S, Viola M. Inhibition of growth factorinduced differentiation of PC12 cells by microinjection of antibody to ras p21. Cell 1986; 319: 680-682.
46. Stephens RD, Loeb D, Copeland T, et al. Trk receptors use redundant signal transduction pathways involving SHC and PLC gamma 1 to mediate NGF responses. Neuron 1994; 12: 691-705.
47. Rozakis-Adcock M, McGlade J, Mbamulu G, et al. Association of the She and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases. Nature 1992; 360: 689-692.
48. Lowenstein E, Daly R, Batzer A, et al. The SH2 and SH3 domaincontaining protein GRB2 links receptor tyrosine kinases to ras signalling. Cell 1992; 70: 431-442.
49. McCormick F. Activators and effectors of ras p21 proteins. Curr Opin Genet Devel 1994; 4: 71-76.
50. Thomas SM, DeMarco M, D'Arcangelo G, Holegoua S, Brugge J. Ras is essential for nerve growth factor and phorbol ester induced tyrosine phosphorylation of MAP kinases. Cell 1992; 68: 1031-1040.
51. Wood KW, Samecki C, Roberts TM, Blenis J. Ras mediates nerve growth factor receptor modulation of three signal-transducing protein kinases: MAP kinase, Raf-1, and RSK. Cell 1992; 68: 1041-1050.
52. Leevers SJ, Paterson HF, Marshall CJ. Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane. Nature 1994; 364: 411-414.
53. Marais R, Light Y, Paterson HF, Marshall CJ. Ras recruits Raf-1 to the plasma membrane for activation by tyrosine phopshorylation. EMBO J 1995; 14: 3136-3145.
54. Alessi DR, Saito Y, Campbell DG, et al. Identification of the sites in MAP kinase kinase-1 phosphorylated by p74raf-1. EMBO J 1994; 13: 1610-1619.
55. Cowley S, Paterson H, Kemp P, Marshall CJ. Activation of MAP kinase kinase is necessary and sufficient for PC 12 cell differentiation and for transformation of NIH 3T3 cells. Cell 1994; 77: 841-852.
56. Marshall CJ. MAP kinase kinase kinase, MAP kinase kinase, and MAP kinase. Curr Opin Genet Devel 1994; 4: 82-89.
57. Blenis J. Signal transduction via the MAP kinases: proceed at your own rsk. Proc Natl Acad Sci. 1993; 90: 5889-5892.
58. Marshall CJ. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 1995; 80(2): 179-185.
59. Chen RH, Sarnecki C, Blenis J. Nuclear localization and regulation of erk-and rsk-encoded protein kinases. Mol Cell Biol 1992; 12: 915-927.
60. Greene LA, Burstein DE, Black MM. The role of transcriptiondependent priming in nerve growth factor promoted neurite outgrowth. Dev Biol 1982; 91: 305-316.
61. Chao MV. Growth factor signaling: where is the specificity? Cell 1992a; 68: 995-997.
62. Greenberg ME, Greene LA, Ziff EB. Nerve growth factor and epidermal growth factor induce rapid transient changes in protooncogene transcription in PC 12 cells. J Biol Chem 1985; 260: 14101-14110.
63. Sheng M, Greenberg ME. The regulation and function of c-fos and other immediate early genes in the nervous system. Neuron 1990; 4: 477-485.
64. Herschman H. Primary response genes induced by growth factor and tumor promoters. Annu Rev Biochem 1991; 60: 281-319.
65. Curran T, Franza BRJ. Fos and Jun: the AP-1 connection. Cell 1988; 55: 395-397.
66. Johnson RS, Spiegelman BM, Papaioannou VE. Pleitropic effects of a null mutation in the c-fos proto-oncogene. Cell 1992; 74: 577-586.
67. Morgan JI, Curran T. Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun. Ann Rev Neurosci 1991; 14: 421-451.
68. Greenberg ME, Hermanowski AL, Ziff EB. Effect of protein synthesis inhibitors on growth factor activation of c-fos, c-myc, and actin gene transcription. Mol Cell Biol 1986; 6: 1050-1057.
69. Treisman R. Transient accumulation of c-fos RNA following serum stimulation requires a conserved 5' element and c-fos 3' sequences. Cell 1985; 42: 567-574.
70. Hayes TE, Kitchen AM, Cochran BH. Inducible binding of a factor to the c-fos regulatory region. Proc Natl Acad Sci USA 1987; 84: 1272-1276.
71. Sheng M, Dougan ST, McFadden G, Greenberg ME. Calcium and growth factor pathways of c-fos transcriptional activation require distinct upstream regulatory sequences. Mol Cell Biol 1988; 8: 2787-2796.
72. Sassone-Corsi P, Visvader J, Ferland L, Mellon P, Verma IM. Induction of proto-oncogene fos transcription through the adenylate cyclase pathway: characterization of a cAMP-response element. Genes Dev 1988; 2: 1529-1538.
73. Fisch TM, Prywes R, Roeder RG. c-fos sequences necessary for basal expression and induction by epidermal growth factor, 12-O-tetradecanoyl phorbol-13-acetate, and the calcium ionophore. Mol Cell Biol 1987; 7: 3490-3496.
74. Berkowitz LA, Riabowal KT, Gilman MZ. Multiple sequence elements of a single functional class are required for cyclic AMP responsiveness of the mouse c-fos promoter. Mol Cell Biol 1989; 9: 4272-4281.
75. Treisman R. The serum response element. Trends Bioch Sci 1992; 17: 423-426.
76. Treisman R. Identification of a protein binding site that mediates transcriptional response of the cfos gene to serum factors. Cell 1986; 46: 567-574.
77. Gilman MZ, Wilson RN, Weinberg RA. Multiple protein binding sites in the 5'-flanking region regulate cfos expression. Mol Cell Biol 1986; 6: 4305-4315.
78. Greenberg ME, Siegfried Z, Ziff EB. Mutation of the c-fos gene dyad symmetry element inhibits serum inducibility of transcription in vivo and the nuclear regulatory factor binding in vitro. Mol Cell Biol 1987; 7: 1217-1225.
79. Rivera VM, Sheng M, Greenberg ME. The inner core of the serum response element mediates both the rapid induction and subsequent repression of c-fos transcription following serum stimulation. Genes Dev 1990; 4: 255-268.
80. Bonni A, Ginty DD, Dudek H, Greenberg ME. Serine 133-phosphorylated CREB induces transcription via a cooperative mechanism that may confer specificity to neurotrophin signals. Mol Cell Neurosci 1995; 6(2): 168-183.
81. Rivera VM, Miranti CK, Misra RP, et al. A growth factor-induced kinase phosphorylates the serum response factor at a site that regulates its DNA-binding activity. Mol Cell Biol 1993; 13: 6260-6273.
82. Miranti CK, Ginty DD, Huang G, Chatila T, Greenberg ME. Calcium activates serum response factor-dependent transcription by a Ras-and Elk-1-independent mechanism that involves a Ca2+/calmodulin-dependent kinase. Mol Cell Biol 1995; 15(7): 3672-3684.
83. Dalton S, Treisman R. Characterization of SAP-1, a protein recruited by serum response factor to the c-fos serum response element. Cell 1992; 68: 597-612.
84. TCF. Nature 1991; 354: 531-534.
85. TCF by MAP kinase stimulates ternary complex formation at the c-fos promoter. Nature 1992; 358: 414-417.
86. Marais R, Wynne J, Treisman R. The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain. Cell 1993; 73: 381-393.
87. Zinck R, Hipskind RA, Pingoud V, Nordheim A. c-fos transcriptional activation and repression correlate temporally with the phosphorylation status of TCF. EMBO J 1993; 12: 2377-2387.
88. Ryan WA, Franza Jr. BR, Gilman MZ. Two distinct cellular phosphoproteins bind to the c-fos serum element. EMBO J 1989; 8: 1785-1792.
89. Walsh K. Cross-binding of factors to functionally different promoter elements in c-fos and skeletal actin genes. Mol Cell Biol 1989; 9: 2191-2201.
90. Natesan S, Gilman MZ. DNA bending and orientation-dependent function of YY1 in the c-fos promoter. Genes Dev 1993; 7: 2497-2509.
91. Gualberto AD, LePage G, Pons SL, et al. Functional antagonism between YY1 and the serum response factor. Mol Cell Biol 1992; 12: 4209-4214.
92. Natesan S, Oilman M. YY1 facilitates the association of serum response factor with the c-fos serum response element. Mol Cell Biol 1995; 15(11): 5975-5982.
93. Gruenberg DA, Natesan S, Alexandre C, Oilman MZ. Human and Drosophila homeodomain proteins that enhance the DNA-binding activity of serum response factor. Science 1992; 257: 1089-1094.
94. Ginty DD, Bonni A, Greenberg ME. NGF activates a Ras-dependent protein kinase that stimulates c-fos transcription via phosphorylation of CREB. Cell 1994; 77: 713-725.
95. Fisch TM, Prywes R, Simon MC, Roeder RG. Multiple sequence elements in the c-fos promoter mediate induction by cAMP. Genes Dev 1989; 3: 198-211.
96. Brindle PK, Montminy MR. The CREB family of transcription factors. Cur Opin Gen Dev 1992; 2: 199-204.
97. Meyer TE, Habener JF. Cyclic adenosine 3' ,5' -monophosphate response element binding protein (CREB) and related transcription-activating deoxyribonucleic acid-binding proteins. Endocrine Rev 1993; 14: 269-290.
98. +2-regulated transcription factor phosphorylated by CaM kinases. Science 1991; 252: 1427-1430.
99. Gonzalez GA, Montminy MR. Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at Serine 133. Cell 1989; 59: 675-680.
100. Xing J, Ginty DD, Greenberg ME. Coupling of the Ras-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase. Science 1996; 273: 959-963.
101. Chrivia JC, Kwok RPS, Lamb N, et al. Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature 1993; 365: 855-859.
102. Kwok RPS, Lundblad JR, Chrivia JC, et al. Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature 1994; 370: 223-226.
103. Traverse S, Seedorf K, Paterson H, et al. EGF triggers neuronal differentiation of PC12 cells that overexpress the EGF receptor. Curr Biol 1994; 4: 694-701.
104. Hu Q, Klippel A, Muslin AJ, Fantl WJ, Williams LT. Ras-dependent induction of cellular responses by constitutively active phosphatidylinositol-3 kinase. Science 1995; 268: 100-102.
105. Yao R, Cooper GM. Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science 1995; 267: 2003-2006.
106. Divecha N, Irvine RF. Phospholipid signaling. Cell 1995; 80: 269-278.
107. Franke TF, Kaplan DR, Cantley LC. PI3K: downstream AK Tion blocks apoptosis. Cell 1997; 88: 435-437.
108. Burgering B, Coffer P. Protein kinase B (Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 1995; 376: 599-602.
109. Franke TF, Yang SI, Chan TO, et al. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 1995; 81: 727-736.
110. Dudek H, Datta SR, Franke TF, et al. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 1997; 275: 661-665.
111. S6K activation mediated by phosphatidylinositol-3-OH kinase. Nature 1994; 370: 71-75.
112. de Groot RP, Ballou LM, Sassone-Corsi P. Positive regulation of the cAMP-responsive activator CREM by the p70 S6 kinase: an alternative route to mitogen-induced gene expression. Cell 1994; 79: 81-91.
113. Rabin S, Cleghorn V, Kaplan DR. SNT, a differentiation-specific target of neurotrophic factor-induced tyrosine kinase activity in neurons and PC12 cells. Mol Cell Biol 1993; 13: 2203-2213.
114. Peng X, Greene L, Kaplan DR, Stephens R. Deletion of a conserved juxtamembrane sequence in Trk abolishes NGF-promoted neuritogenesis. Neuron 1995; 15: 395-406.
115. Hill CS, Treisman R. Transcriptional regulation by extracellular signals: mechanisms and specificity. Cell 1995; 80: 199-211.
116. Gupta S, Campbell D, Derijard B, Davis RJ. Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science 1995; 267: 389-393.
117. Whitmarsh AJ, Shore P, Sharrocks AD, Davis RJ. Integration of MAP kinase signal transduction pathways at the serum response element. Science 1995; 269: 403-407.
118. Vojtek A, Cooper JA. Rho family members: activators of MAP kinase cascades. Cell 1995; 82: 527-529.
119. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995; 270: 1326-1334.
120. Verheij M, Bose R, Lin XH, et al. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature 1996; 380: 75-79.
121. Joseph C, Byun H, Bittman R, Kolesnick R. Substrate recognition by ceramide-activated protein kinase. J Biol Chem 1994; 268: 20002-20006.
122. Yao B, Zhang Y, Delikat S, et al. Phosphorylation of Raf by ceramide-activated protein kinase. Nature 1995; 378: 307-310.
123. Dobrowsky RT, Werner MH, Castellino AM, Chao MV, Hannun YA. Activation of the sphingomyelinase cycle through the lowaffinity neurotrophin receptor. Science 1994; 265: 1596-1599.
124. Barker PA, Shooter EP. Disruption of NGF binding to the low affinity neurotrophin receptor p75-LNTR reduces NGF binding to TrKA on PC12 cells. Neuron 1994; 13: 203-215.
125. Davies AM, Lee K-F, Jaenisch R. p75-deficient trigeminal sensory neurons have an altered response to NGF but not to other neurotrophins. Neuron 1993; 11: 565-574.
126. Rabizadeh S, Oh J, Zhong LT, et al. Induction of apoptosis by the low-affinity NGF receptor. Science 1993; 261: 345-348.
127. NGFR-deficient mice. Science 1996; 274: 1729-1732.
128. Feinstein E, Kimchi A, Wallach D, Boldin M, Varfolomeev E. The death domain: a module shared by proteins with diverse cellular functions. Trends Biochem Sci 1995; 20: 342-344.
129. Anton ES, Weskamp G, Reichardt LF, Matthew WD. Proc Natl Acad Sci USA 1994; 91: 2795-2799.
130. Petrij F, Giles RH, Dauwerse HG, et al. Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature 1995; 376(6538): 348-351.
131. Trivier E, De Cesare D, Jacquot S, et al. Mutations in the kinse Rsk-2 associated with Coffin-Lowry syndrome. Nature 1996; 384: 567-570.